Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 231 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2784 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-02 2024-02-23 218376
APO-ATORVASTATIN 40MG TABLET Resolved 2024-02-02 2024-03-22 218373
APO-LEVETIRACETAM 750MG TABLET Resolved 2024-02-02 2024-03-15 218370
APO-AMOXI CLAV 125MG 875MG TABLET Resolved 2024-01-26 2024-03-01 217490
APO-GLICLAZIDE 80MG TABLET Resolved 2024-01-26 2024-03-15 217487
APO-BUSPIRONE 10MG TABLET Actual shortage 2024-01-26 2024-02-02 217484
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-05-17 217481
APO-ATORVASTATIN 80MG TABLET Resolved 2024-01-26 2024-02-16 217478
ZAMINE 28 0.03MG 3MG TABLET Resolved 2024-01-26 2024-03-08 217475
APO-MIDODRINE 5MG TABLET Actual shortage 2024-01-26 2024-04-05 217472
APO-TRYPTOPHAN 500MG TABLET Resolved 2024-01-26 2024-04-05 217469
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-02-23 217300
APO-FINGOLIMOD 0.5MG CAPSULE Actual shortage 2024-01-19 2024-05-10 216744
APO-PREGABALIN 75MG CAPSULE Actual shortage 2024-01-19 2024-05-08 216741
APO-PREGABALIN 50MG CAPSULE Anticipated shortage 2024-01-19 2024-01-19 216738
APO-PREGABALIN 300MG CAPSULE Anticipated shortage 2024-01-19 2024-01-19 216735
APO-PREGABALIN 25MG CAPSULE Actual shortage 2024-01-19 2024-05-08 216732
APO-PREGABALIN 225MG CAPSULE Anticipated shortage 2024-01-19 2024-01-19 216729
APO-PREGABALIN 150MG CAPSULE Anticipated shortage 2024-01-19 2024-01-19 216726
APO-OLMESARTAN/HCTZ 12.5MG 40MG TABLET Anticipated shortage 2024-01-19 2024-01-19 216723

Showing 161 to 180 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TELMISARTAN 40MG TABLET Discontinued 2019-01-04 2019-01-04 71345
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
NAPROXEN SODIUM TABLETS 220MG TABLET Discontinued 2019-01-04 2019-01-04 71228
ACETAMINOPHEN CAPLETS 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71225
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71222
ACETAMINOPHEN TABLETS USP 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71219
ACETAMINOPHEN TABLETS USP 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71216
APO-LOSARTAN 100MG TABLET Discontinued 2019-01-04 2019-01-04 71213
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
ACID CONTROL Discontinued 2019-01-04 2019-01-04 71198
APO-CEFPROZIL 250MG TABLET Discontinued 2019-01-04 2019-02-21 71195
ACETAMINOPHEN HEADACHE ULTRA RELIEF 500MG 65MG TABLET Discontinued 2019-01-04 2019-01-04 71192

Showing 61 to 80 of 356